{'fraction_non_alphanumeric': 0.029357798165137616, 'fraction_numerical': 0.05688073394495413, 'mean_word_length': 4.934782608695652, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
INTRAMUSCULAR ADMINISTRATION OF 15‐METHYL PROSTAGLANDIN F2α FOR INDUCTION OF LABOUR IN PATIENTS WITH INTRAUTERINE FETAL DEATH OR AN ANENCEPHALIC FETUS

The 15‐methyl analogue of PGF2α was administered intramuscularly between 23 and 36 weeks of gestation, to induce labour in 11 mothers with intrauterine fetal death and two with anencephaly. All were delivered within 20 hours (mean 7 hours). The mean dose of 15‐me‐PGF2α was 400 μg (range 100 to 700) given by a mean of 3·1 (range 1 to 7) injections. Diarrhoea was the most frequent sideeffect.